Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancer

Lung Cancer

Volumn 77, Issue 3, 2012, Pages 585-592

  Lo, Fang Yi ^a   Chen, Hsiung Ting ^a   Cheng, Hung Chi ^a   Hsu, Han Shui ^b   Wang, Yi Ching ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Lung cancer; Metastasis; Oncogene; PAFAH1B1; Poor survival

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; ONCOGENE; PAFAH1B1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AGED; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASM TRANSPLANTATION; RNA INTERFERENCE;

EID: 84865197451     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.05.105     Document Type: Article

References (19)

1. Davies J.J., Wilson I.M., Lam W.L. Array CGH technologies and their applications to cancer genomes. Chromosome Res 2005, 13:237-248.
2. Schwab M. Oncogene amplification in solid tumors. Semin Cancer Biol 1999, 9:319-325.
3. Ledbetter S.A., Kuwano A., Dobyns W.B., Ledbetter D.H. Microdeletions of chromosome 17p13 as a cause of isolated lissencephaly. Am J Hum Genet 1992, 50:182-189.
4. Hattori M., Adachi H., Tsujimoto M., Arai H., Inoue K. Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase. Nature 1994, 370:216-218.
5. Lo Nigro C., Chong C.S., Smith A.C., Dobyns W.B., Carrozzo R., Ledbetter D.H. Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum Mol Genet 1997, 6:157-164.
6. Cardoso C., Leventer R.J., Matsumoto N., Kuc J.A., Ramocki M.B., Mewborn S.K., et al. The location and type of mutation predict malformation severity in isolated lissencephaly caused by abnormalities within the LIS1 gene. Hum Mol Genet 2000, 9:3019-3028.
7. Soukoulis V., Reddy S., Pooley R.D., Feng Y., Walsh C.A., Bader D.M. Cytoplasmic LEK1 is a regulator of microtubule function through its interaction with the LIS1 pathway. Proc Natl Acad Sci USA 2005, 102:8549-8554.
8. Suzuki S.O., McKenney R.J., Mawatari S.Y., Mizuguchi M., Mikami A., Iwaki T., et al. Expression patterns of LIS1, dynein and their interaction partners dynactin, NudE, NudEL and NudC in human gliomas suggest roles in invasion and proliferation. Acta Neuropathol 2007, 113:591-599.
9. Wynshaw-Boris A. Lissencephaly and LIS1: insights into the molecular mechanisms of neuronal migration and development. Clin Genet 2007, 72:296-304.
10. Wynshaw-Boris A., Pramparo T., Youn Y.H., Hirotsune S. Lissencephaly: mechanistic insights from animal models and potential therapeutic strategies. Semin Cell Dev Biol 2010, 21:823-830.
11. Messi E., Florian M.C., Caccia C., Zanisi M., Maggi R. Retinoic acid reduces human neuroblastoma cell migration and invasiveness: effects on DCX, LIS1, neurofilaments-68 and vimentin expression. BMC Cancer 2008, 8:30.
12. Aumais J.P., Tunstead J.R., McNeil R.S., Schaar B.T., McConnell S.K., Lin S.H., et al. NudC associates with Lis1 and the dynein motor at the leading pole of neurons. J Neurosci 2001, 21:RC187.
13. Ford N.L., Graham K.C., Groom A.C., Macdonald I.C., Chambers A.F., Holdsworth D.W. Time-course characterization of the computed tomography contrast enhancement of an iodinated blood-pool contrast agent in mice using a volumetric flat-panel equipped computed tomography scanner. Invest Radiol 2006, 41:384-390.
14. Tian Y., Zhang Y., Hurd L., Hannenhalli S., Liu F., Lu M.M., et al. Regulation of lung endoderm progenitor cell behavior by miR302/367. Development 2011, 138:1235-1245.
15. Subramanyam D., Lamouille S., Judson R.L., Liu J.Y., Bucay N., Derynck R., et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol 2011, 29:443-448.
16. Hirotsune S., Fleck M.W., Gambello M.J., Bix G.J., Chen A., Clark G.D., et al. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat Genet 1998, 19:333-339.
17. Cheng H.C., Abdel-Ghany M., Pauli B.U. A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J Biol Chem 2003, 278:24600-24607.
18. Nam J.M., Onodera Y., Bissell M.J., Park C.C. Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. Cancer Res 2010, 70:5238-5248.
19. Xing Z., Tang X., Gao Y., Da L., Song H., Wang S., et al. The human LIS1 is downregulated in hepatocellular carcinoma and plays a tumor suppressor function. Biochem Biophys Res Commun 2011, 409:193-199.